Global Quadrivalent Meningococcal Vaccine Supply, Demand and Key Producers, 2024-2030

Page: 109

Published Date: 02 Mar 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Quadrivalent Meningococcal Vaccine market size is expected to reach $ 279.3 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

Many countries have implemented meningococcal vaccination programs, especially targeting high-risk groups such as infants, adolescents and university students. Inclusion or recommendation of quadrivalent meningococcal vaccines in national immunization schedules can significantly influence the market demand.

The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.

This report studies the global Quadrivalent Meningococcal Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Quadrivalent Meningococcal Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Quadrivalent Meningococcal Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Quadrivalent Meningococcal Vaccine total production and demand, 2019-2030, (K Units)
Global Quadrivalent Meningococcal Vaccine total production value, 2019-2030, (USD Million)
Global Quadrivalent Meningococcal Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Quadrivalent Meningococcal Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Quadrivalent Meningococcal Vaccine domestic production, consumption, key domestic manufacturers and share
Global Quadrivalent Meningococcal Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Quadrivalent Meningococcal Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Quadrivalent Meningococcal Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Quadrivalent Meningococcal Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi-Pasteur, Walvax, Chengdu Kanghua Biological Products Co., Ltd., Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd., Zhejiang Tianyuan Biopharmaceutical Co., Ltd., Beijing Institute of Biological Products Co., Ltd., CanSino Biological Co., Ltd., Hualan Biological Vaccine Co., Ltd. and Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Quadrivalent Meningococcal Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Quadrivalent Meningococcal Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Quadrivalent Meningococcal Vaccine Market, Segmentation by Type
Polysaccharide Vaccine
Conjugate Vaccine

Global Quadrivalent Meningococcal Vaccine Market, Segmentation by Application
Hospital
Clinic

Companies Profiled:
Sanofi-Pasteur
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

Key Questions Answered
1. How big is the global Quadrivalent Meningococcal Vaccine market?
2. What is the demand of the global Quadrivalent Meningococcal Vaccine market?
3. What is the year over year growth of the global Quadrivalent Meningococcal Vaccine market?
4. What is the production and production value of the global Quadrivalent Meningococcal Vaccine market?
5. Who are the key producers in the global Quadrivalent Meningococcal Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Quadrivalent Meningococcal Vaccine Introduction
    1.2 World Quadrivalent Meningococcal Vaccine Supply & Forecast
        1.2.1 World Quadrivalent Meningococcal Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Quadrivalent Meningococcal Vaccine Production (2019-2030)
        1.2.3 World Quadrivalent Meningococcal Vaccine Pricing Trends (2019-2030)
    1.3 World Quadrivalent Meningococcal Vaccine Production by Region (Based on Production Site)
        1.3.1 World Quadrivalent Meningococcal Vaccine Production Value by Region (2019-2030)
        1.3.2 World Quadrivalent Meningococcal Vaccine Production by Region (2019-2030)
        1.3.3 World Quadrivalent Meningococcal Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Quadrivalent Meningococcal Vaccine Production (2019-2030)
        1.3.5 Europe Quadrivalent Meningococcal Vaccine Production (2019-2030)
        1.3.6 China Quadrivalent Meningococcal Vaccine Production (2019-2030)
        1.3.7 Japan Quadrivalent Meningococcal Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Quadrivalent Meningococcal Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Quadrivalent Meningococcal Vaccine Major Market Trends

2 Demand Summary
    2.1 World Quadrivalent Meningococcal Vaccine Demand (2019-2030)
    2.2 World Quadrivalent Meningococcal Vaccine Consumption by Region
        2.2.1 World Quadrivalent Meningococcal Vaccine Consumption by Region (2019-2024)
        2.2.2 World Quadrivalent Meningococcal Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Quadrivalent Meningococcal Vaccine Consumption (2019-2030)
    2.4 China Quadrivalent Meningococcal Vaccine Consumption (2019-2030)
    2.5 Europe Quadrivalent Meningococcal Vaccine Consumption (2019-2030)
    2.6 Japan Quadrivalent Meningococcal Vaccine Consumption (2019-2030)
    2.7 South Korea Quadrivalent Meningococcal Vaccine Consumption (2019-2030)
    2.8 ASEAN Quadrivalent Meningococcal Vaccine Consumption (2019-2030)
    2.9 India Quadrivalent Meningococcal Vaccine Consumption (2019-2030)

3 World Quadrivalent Meningococcal Vaccine Manufacturers Competitive Analysis
    3.1 World Quadrivalent Meningococcal Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Quadrivalent Meningococcal Vaccine Production by Manufacturer (2019-2024)
    3.3 World Quadrivalent Meningococcal Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Quadrivalent Meningococcal Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Quadrivalent Meningococcal Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Quadrivalent Meningococcal Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Quadrivalent Meningococcal Vaccine in 2023
    3.6 Quadrivalent Meningococcal Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Quadrivalent Meningococcal Vaccine Market: Region Footprint
        3.6.2 Quadrivalent Meningococcal Vaccine Market: Company Product Type Footprint
        3.6.3 Quadrivalent Meningococcal Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Quadrivalent Meningococcal Vaccine Production Value Comparison
        4.1.1 United States VS China: Quadrivalent Meningococcal Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Quadrivalent Meningococcal Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Quadrivalent Meningococcal Vaccine Production Comparison
        4.2.1 United States VS China: Quadrivalent Meningococcal Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Quadrivalent Meningococcal Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Quadrivalent Meningococcal Vaccine Consumption Comparison
        4.3.1 United States VS China: Quadrivalent Meningococcal Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Quadrivalent Meningococcal Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Quadrivalent Meningococcal Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Quadrivalent Meningococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Quadrivalent Meningococcal Vaccine Production (2019-2024)
    4.5 China Based Quadrivalent Meningococcal Vaccine Manufacturers and Market Share
        4.5.1 China Based Quadrivalent Meningococcal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Quadrivalent Meningococcal Vaccine Production (2019-2024)
    4.6 Rest of World Based Quadrivalent Meningococcal Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Quadrivalent Meningococcal Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Quadrivalent Meningococcal Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Quadrivalent Meningococcal Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Polysaccharide Vaccine
        5.2.2 Conjugate Vaccine
    5.3 Market Segment by Type
        5.3.1 World Quadrivalent Meningococcal Vaccine Production by Type (2019-2030)
        5.3.2 World Quadrivalent Meningococcal Vaccine Production Value by Type (2019-2030)
        5.3.3 World Quadrivalent Meningococcal Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Quadrivalent Meningococcal Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
    6.3 Market Segment by Application
        6.3.1 World Quadrivalent Meningococcal Vaccine Production by Application (2019-2030)
        6.3.2 World Quadrivalent Meningococcal Vaccine Production Value by Application (2019-2030)
        6.3.3 World Quadrivalent Meningococcal Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Sanofi-Pasteur
        7.1.1 Sanofi-Pasteur Details
        7.1.2 Sanofi-Pasteur Major Business
        7.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product and Services
        7.1.4 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Sanofi-Pasteur Recent Developments/Updates
        7.1.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
    7.2 Walvax
        7.2.1 Walvax Details
        7.2.2 Walvax Major Business
        7.2.3 Walvax Quadrivalent Meningococcal Vaccine Product and Services
        7.2.4 Walvax Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Walvax Recent Developments/Updates
        7.2.6 Walvax Competitive Strengths & Weaknesses
    7.3 Chengdu Kanghua Biological Products Co., Ltd.
        7.3.1 Chengdu Kanghua Biological Products Co., Ltd. Details
        7.3.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
        7.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
        7.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
        7.3.6 Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
    7.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
        7.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Details
        7.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
        7.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
        7.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
        7.4.6 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
        7.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Details
        7.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
        7.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
        7.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
        7.5.6 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.6 Beijing Institute of Biological Products Co., Ltd.
        7.6.1 Beijing Institute of Biological Products Co., Ltd. Details
        7.6.2 Beijing Institute of Biological Products Co., Ltd. Major Business
        7.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
        7.6.4 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
        7.6.6 Beijing Institute of Biological Products Co., Ltd. Competitive Strengths & Weaknesses
    7.7 CanSino Biological Co., Ltd.
        7.7.1 CanSino Biological Co., Ltd. Details
        7.7.2 CanSino Biological Co., Ltd. Major Business
        7.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
        7.7.4 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 CanSino Biological Co., Ltd. Recent Developments/Updates
        7.7.6 CanSino Biological Co., Ltd. Competitive Strengths & Weaknesses
    7.8 Hualan Biological Vaccine Co., Ltd.
        7.8.1 Hualan Biological Vaccine Co., Ltd. Details
        7.8.2 Hualan Biological Vaccine Co., Ltd. Major Business
        7.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
        7.8.4 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
        7.8.6 Hualan Biological Vaccine Co., Ltd. Competitive Strengths & Weaknesses
    7.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
        7.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Details
        7.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
        7.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
        7.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
        7.9.6 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Quadrivalent Meningococcal Vaccine Industry Chain
    8.2 Quadrivalent Meningococcal Vaccine Upstream Analysis
        8.2.1 Quadrivalent Meningococcal Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Quadrivalent Meningococcal Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Quadrivalent Meningococcal Vaccine Production Mode
    8.6 Quadrivalent Meningococcal Vaccine Procurement Model
    8.7 Quadrivalent Meningococcal Vaccine Industry Sales Model and Sales Channels
        8.7.1 Quadrivalent Meningococcal Vaccine Sales Model
        8.7.2 Quadrivalent Meningococcal Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Quadrivalent Meningococcal Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Quadrivalent Meningococcal Vaccine Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Quadrivalent Meningococcal Vaccine Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Quadrivalent Meningococcal Vaccine Production Value Market Share by Region (2019-2024)
    Table 5. World Quadrivalent Meningococcal Vaccine Production Value Market Share by Region (2025-2030)
    Table 6. World Quadrivalent Meningococcal Vaccine Production by Region (2019-2024) & (K Units)
    Table 7. World Quadrivalent Meningococcal Vaccine Production by Region (2025-2030) & (K Units)
    Table 8. World Quadrivalent Meningococcal Vaccine Production Market Share by Region (2019-2024)
    Table 9. World Quadrivalent Meningococcal Vaccine Production Market Share by Region (2025-2030)
    Table 10. World Quadrivalent Meningococcal Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Quadrivalent Meningococcal Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Quadrivalent Meningococcal Vaccine Major Market Trends
    Table 13. World Quadrivalent Meningococcal Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Quadrivalent Meningococcal Vaccine Consumption by Region (2019-2024) & (K Units)
    Table 15. World Quadrivalent Meningococcal Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Quadrivalent Meningococcal Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Quadrivalent Meningococcal Vaccine Producers in 2023
    Table 18. World Quadrivalent Meningococcal Vaccine Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Quadrivalent Meningococcal Vaccine Producers in 2023
    Table 20. World Quadrivalent Meningococcal Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Quadrivalent Meningococcal Vaccine Company Evaluation Quadrant
    Table 22. World Quadrivalent Meningococcal Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Quadrivalent Meningococcal Vaccine Production Site of Key Manufacturer
    Table 24. Quadrivalent Meningococcal Vaccine Market: Company Product Type Footprint
    Table 25. Quadrivalent Meningococcal Vaccine Market: Company Product Application Footprint
    Table 26. Quadrivalent Meningococcal Vaccine Competitive Factors
    Table 27. Quadrivalent Meningococcal Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Quadrivalent Meningococcal Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Quadrivalent Meningococcal Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Quadrivalent Meningococcal Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Quadrivalent Meningococcal Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Quadrivalent Meningococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Quadrivalent Meningococcal Vaccine Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Quadrivalent Meningococcal Vaccine Production Market Share (2019-2024)
    Table 37. China Based Quadrivalent Meningococcal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Quadrivalent Meningococcal Vaccine Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Quadrivalent Meningococcal Vaccine Production Market Share (2019-2024)
    Table 42. Rest of World Based Quadrivalent Meningococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Quadrivalent Meningococcal Vaccine Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Quadrivalent Meningococcal Vaccine Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Quadrivalent Meningococcal Vaccine Production Market Share (2019-2024)
    Table 47. World Quadrivalent Meningococcal Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Quadrivalent Meningococcal Vaccine Production by Type (2019-2024) & (K Units)
    Table 49. World Quadrivalent Meningococcal Vaccine Production by Type (2025-2030) & (K Units)
    Table 50. World Quadrivalent Meningococcal Vaccine Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Quadrivalent Meningococcal Vaccine Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Quadrivalent Meningococcal Vaccine Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Quadrivalent Meningococcal Vaccine Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Quadrivalent Meningococcal Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Quadrivalent Meningococcal Vaccine Production by Application (2019-2024) & (K Units)
    Table 56. World Quadrivalent Meningococcal Vaccine Production by Application (2025-2030) & (K Units)
    Table 57. World Quadrivalent Meningococcal Vaccine Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Quadrivalent Meningococcal Vaccine Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Quadrivalent Meningococcal Vaccine Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Quadrivalent Meningococcal Vaccine Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi-Pasteur Major Business
    Table 63. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product and Services
    Table 64. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Sanofi-Pasteur Recent Developments/Updates
    Table 66. Sanofi-Pasteur Competitive Strengths & Weaknesses
    Table 67. Walvax Basic Information, Manufacturing Base and Competitors
    Table 68. Walvax Major Business
    Table 69. Walvax Quadrivalent Meningococcal Vaccine Product and Services
    Table 70. Walvax Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Walvax Recent Developments/Updates
    Table 72. Walvax Competitive Strengths & Weaknesses
    Table 73. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 74. Chengdu Kanghua Biological Products Co., Ltd. Major Business
    Table 75. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
    Table 76. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
    Table 78. Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
    Table 79. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 80. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
    Table 81. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
    Table 82. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
    Table 84. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    Table 85. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 86. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
    Table 87. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
    Table 88. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
    Table 90. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    Table 91. Beijing Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 92. Beijing Institute of Biological Products Co., Ltd. Major Business
    Table 93. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
    Table 94. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
    Table 96. Beijing Institute of Biological Products Co., Ltd. Competitive Strengths & Weaknesses
    Table 97. CanSino Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 98. CanSino Biological Co., Ltd. Major Business
    Table 99. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
    Table 100. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. CanSino Biological Co., Ltd. Recent Developments/Updates
    Table 102. CanSino Biological Co., Ltd. Competitive Strengths & Weaknesses
    Table 103. Hualan Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 104. Hualan Biological Vaccine Co., Ltd. Major Business
    Table 105. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
    Table 106. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
    Table 108. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 109. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
    Table 110. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
    Table 111. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 112. Global Key Players of Quadrivalent Meningococcal Vaccine Upstream (Raw Materials)
    Table 113. Quadrivalent Meningococcal Vaccine Typical Customers
    Table 114. Quadrivalent Meningococcal Vaccine Typical Distributors
List of Figure
    Figure 1. Quadrivalent Meningococcal Vaccine Picture
    Figure 2. World Quadrivalent Meningococcal Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Quadrivalent Meningococcal Vaccine Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Quadrivalent Meningococcal Vaccine Production (2019-2030) & (K Units)
    Figure 5. World Quadrivalent Meningococcal Vaccine Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Quadrivalent Meningococcal Vaccine Production Value Market Share by Region (2019-2030)
    Figure 7. World Quadrivalent Meningococcal Vaccine Production Market Share by Region (2019-2030)
    Figure 8. North America Quadrivalent Meningococcal Vaccine Production (2019-2030) & (K Units)
    Figure 9. Europe Quadrivalent Meningococcal Vaccine Production (2019-2030) & (K Units)
    Figure 10. China Quadrivalent Meningococcal Vaccine Production (2019-2030) & (K Units)
    Figure 11. Japan Quadrivalent Meningococcal Vaccine Production (2019-2030) & (K Units)
    Figure 12. Quadrivalent Meningococcal Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Quadrivalent Meningococcal Vaccine Consumption (2019-2030) & (K Units)
    Figure 15. World Quadrivalent Meningococcal Vaccine Consumption Market Share by Region (2019-2030)
    Figure 16. United States Quadrivalent Meningococcal Vaccine Consumption (2019-2030) & (K Units)
    Figure 17. China Quadrivalent Meningococcal Vaccine Consumption (2019-2030) & (K Units)
    Figure 18. Europe Quadrivalent Meningococcal Vaccine Consumption (2019-2030) & (K Units)
    Figure 19. Japan Quadrivalent Meningococcal Vaccine Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Quadrivalent Meningococcal Vaccine Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Quadrivalent Meningococcal Vaccine Consumption (2019-2030) & (K Units)
    Figure 22. India Quadrivalent Meningococcal Vaccine Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Quadrivalent Meningococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Quadrivalent Meningococcal Vaccine Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Quadrivalent Meningococcal Vaccine Markets in 2023
    Figure 26. United States VS China: Quadrivalent Meningococcal Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Quadrivalent Meningococcal Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Quadrivalent Meningococcal Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Quadrivalent Meningococcal Vaccine Production Market Share 2023
    Figure 30. China Based Manufacturers Quadrivalent Meningococcal Vaccine Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Quadrivalent Meningococcal Vaccine Production Market Share 2023
    Figure 32. World Quadrivalent Meningococcal Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Quadrivalent Meningococcal Vaccine Production Value Market Share by Type in 2023
    Figure 34. Polysaccharide Vaccine
    Figure 35. Conjugate Vaccine
    Figure 36. World Quadrivalent Meningococcal Vaccine Production Market Share by Type (2019-2030)
    Figure 37. World Quadrivalent Meningococcal Vaccine Production Value Market Share by Type (2019-2030)
    Figure 38. World Quadrivalent Meningococcal Vaccine Average Price by Type (2019-2030) & (US$/Unit)
    Figure 39. World Quadrivalent Meningococcal Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Quadrivalent Meningococcal Vaccine Production Value Market Share by Application in 2023
    Figure 41. Hospital
    Figure 42. Clinic
    Figure 43. World Quadrivalent Meningococcal Vaccine Production Market Share by Application (2019-2030)
    Figure 44. World Quadrivalent Meningococcal Vaccine Production Value Market Share by Application (2019-2030)
    Figure 45. World Quadrivalent Meningococcal Vaccine Average Price by Application (2019-2030) & (US$/Unit)
    Figure 46. Quadrivalent Meningococcal Vaccine Industry Chain
    Figure 47. Quadrivalent Meningococcal Vaccine Procurement Model
    Figure 48. Quadrivalent Meningococcal Vaccine Sales Model
    Figure 49. Quadrivalent Meningococcal Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi-Pasteur
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

Related Reports

Global Quadrivalent Meningococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Quadrivalent Meningococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 29 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Quadrivalent Meningococcal Vaccine market size was valued at USD 190.4 million in 2023 and is forecast to a readjusted size of USD 279.3 million by 2030 with a CAGR of 5.6% during review period.

Product Tags

Quadrivalent Meningococcal Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>